Predicted to be involved in anterograde synaptic vesicle transport and vesicle-mediated transport. Predicted to be located in membrane. Predicted to be part of AP-3 adaptor complex. Predicted to be active in intracellular membrane-bounded organelle. Orthologous to human AP3S1 (adaptor related protein complex 3 subunit sigma 1); INTERACTS WITH 2,3,7,8-tetrachlorodibenzodioxine; 2,3,7,8-Tetrachlorodibenzofuran; 6-propyl-2-thiouracil.
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AP3S1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AP3S1 mRNA
[Clofibrate co-treated with Acetaminophen] affects the expression of AP3S1 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of AP3S1 mRNA]
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AP3S1 mRNA
[[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of AP3S1 mRNA
[INS protein co-treated with Dexamethasone co-treated with 1-Methyl-3-isobutylxanthine co-treated with Indomethacin co-treated with bisphenol F] results in increased expression of AP3S1 mRNA
[Clofibrate co-treated with Acetaminophen] affects the expression of AP3S1 mRNA and PPARA affects the reaction [[Clofibrate co-treated with Acetaminophen] affects the expression of AP3S1 mRNA]
[perfluorooctane sulfonic acid co-treated with Inulin] results in increased expression of AP3S1 mRNA and [perfluorooctane sulfonic acid co-treated with Pectins] results in increased expression of AP3S1 mRNA
[LDN 193189 co-treated with 4-(5-benzo(1 and 3)dioxol-5-yl-4-pyridin-2-yl-1H-imidazol-2-yl)benzamide co-treated with FGF2 protein] results in increased expression of AP3S1 protein